“American pharma company makes drug with our antibody 47D11” | Inland

According to Grosveld, the Rotterdam antibody “47D11” passed some crucial tests on living things in recent weeks. “The drug will be there in five or six months. This is a very fast process for developing a medicine. ” Grosveld cannot say at this stage which pharmaceutical company is involved.

Grosveld is one of the discoverers of the antibody, the main component of the corona drug. He made his discovery together with fellow scientists Berend Jan Bos (Utrecht University) and Bart Haagmans. “This antibody responds to SARS1, it also works for the current coronavirus, which is also known as SARS2. If there is a SARS3, there is a good chance that it will respond well to that. ”

According to the professor, the impact of the drug can be enormous. “You can use it as a medicine, if you are already infected and as a preventative for high-risk groups.” Grosveld says he received several tons of subsidies from the cabinet for his research.

–